| First Author | Zhou P | Year | 2021 |
| Journal | iScience | Volume | 24 |
| Issue | 6 | Pages | 102645 |
| PubMed ID | 34142067 | Mgi Jnum | J:312216 |
| Mgi Id | MGI:6780802 | Doi | 10.1016/j.isci.2021.102645 |
| Citation | Zhou P, et al. (2021) Arhgef2 regulates neural differentiation in the cerebral cortex through mRNA m(6)A-methylation of Npdc1 and Cend1. iScience 24(6):102645 |
| abstractText | N (6)-methyladenosine (m(6)A) is emerging as a vital factor regulating neural differentiation. Here, we report that deficiency of Arhgef2, a novel cause of a neurodevelopmental disorder we identified recently, impairs neurogenesis, neurite outgrowth, and synaptic formation by regulating m(6)A methylation. Arhgef2 knockout decreases expression of Mettl14 and total m(6)A level significantly in the cerebral cortex. m(6)A sequencing reveals that loss of Arhgef2 reduces m(6)A methylation of 1,622 mRNAs, including Npdc1 and Cend1, which are both strongly associated with cell cycle exit and terminal neural differentiation. Arhgef2 deficiency decreases m(6)A methylations of the Npdc1 and Cend1 mRNAs via down-regulation of Mettl14, and thereby inhibits the translation of Npdc1 and nuclear export of Cend1 mRNAs. Overexpression of Mettl14, Npdc1, and Cend1 rescue the abnormal phenotypes in Arhgef2 knockout mice, respectively. Our study provides a critical insight into a mechanism by which defective Arhgef2 mediates m(6)A-tagged target mRNAs to impair neural differentiation. |
